Apoptosis
Apoptosis, also known as programmed cell death, is rigorously controlled process of cell death that leads to phagocytosis of unwanted cell. It is triggered after sufficient cellular damage and activated through extrinsic or intrinsic pathways. The intrinsic pathway is mainly occurs via release of cytochrome c from the mitochondria and regulates mitochondrial outer membrane permeabilization by Bcl-2 family proteins. The extrinsic pathway is induced by ligand binding to death receptor, such as Fas, TNFαR, DR3, DR4, and DR5. Caspases then cleave target proteins and nuclear lamins to promote DNA degradation, resulting apoptotic cells undergo phagocytosis. In addition, p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some Inhibitors of apoptosis proteins (IAPs), such as XIAP/BIRC4 and Bruce/BIRC6, can block casapse activity through direct binding, while other IAPs, such as cIAP1/BIRC2, cIAP2/BIRC3, act as ubiquitin ligases that target caspases for ubiquitin-mediated degradation. Apoptosis is essential for growth, development and aging in multicellular organisms. Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases, including cancer.
-
BA2912 PhenoxodiolSummary: Phenoxodiol (Idronoxil) is a synthetic analog of Genestein that activates the mitochondrial system, inhibits (an apoptosis inhibitor), and sensitizes cancer cells to Fas-mediated apoptosis. -
BA2913 XZ739Summary: XZ739 is a degrading agent. -
BA2914 hnRNPK-IN-1Summary: hnRNPK-IN-1 is a heterogeneous ribonucleoprotein K-binding ligand with values of 4.6 μM and 2.6 μM measured by SPR and MST, respectively. -
BA2915 DesoxyrhaponticinSummary: Desoxyrhaponticin is an orally effective fatty acid synthase inhibitor with apoptotic effects on human cancer cells. -
BA2916 JNJ-1013Summary: JNJ-1013 is an effective selective degrader. -
BA2917 α-SolanineSummary: Alpha-solanine is a biologically active ingredient in. -
BA2918 INCB-057643Summary: INCB-057643 is a new type. -
BA2919 ImifoplatinSummary: Imifoplatin (PT-112) is a platinum-based active molecule belonging to the phosphoplatinum family. -
BA2921 A-192621Summary: A-192621 is a potent non-peptide, orally active, selective endothelin B receptor antagonist. -
BA2924 AK-778-XXMUSummary: AK-778-XXMU is a potent inhibitor of DNA binding 2 antagonists.


